Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
encorehealthresources.com

See what CB Insights has to offer

Stage

Acquired - II | Acquired

About Encore Health Resources

Encore Health Resources provides world-class industry experts to the healthcare market who have specialized knowledge of the industry's major clinical and business applications. The company assists provider organizations in planning, implementing, and adopting the technologies required to successfully plan for and respond to increased reimbursement and quality challenges.

Encore Health Resources Headquarter Location

P.O. Box 3109 #24350

Houston, Texas, 77253,

United States

877-787-1010

Latest Encore Health Resources News

HIT Industry Mogul Dana Sellers Joins MediQuant Board of Directors

Feb 26, 2019

Most recently, Sellers was co-founder and chief executive officer (CEO) of Encore Health Resources, a provider of HIT consulting, retiring from Encore after it was acquired by emids in 2017. Encore had been named a Modern Healthcare “Best Place to Work” repeatedly since its inception in 2009. “We are delighted to have Dana join the MediQuant board as we navigate a significant new era of growth,” said MediQuant CEO Jim Jacobs. “She brings knowledge, experience, an entrepreneurial spirit and history of dedication to employee and client satisfaction.” Other MediQuant board members include: MediQuant founder and chairman Tony Paparella and Jeff Crisan and Nikhil Marathe of Silversmith Capital Partners. Before starting her own firm, Sellers was president and chief operating officer at Healthlink leading to its acquisition by IBM’s Global Business Solutions. She stayed with IBM for four years as a partner overseeing the U.S. healthcare provider team. “My credo is a great match for the long-term commitment and recent clinical expansion of MediQuant: to offer the best healthcare IT to improve patient care and outcomes,” said Sellers. “It’s exciting to turn my attention to helping healthcare facilities and providers with the smoothest possible transitions to update and upgrade their data systems to meet today’s needs. If we can ease the burden of information management and reporting, we can help make IT a pathway to better and more successful health services.” Sellers also serves on the board of emids. She has served on the boards of CHIME, the CHIME Foundation and the CHIME Education Foundation, and is a recipient of the CHIME Foundation Industry Leader Award. About MediQuant Founded in 1999, and headquartered in Brecksville, Ohio, MediQuant is the leader in enterprise active archiving solutions for hospitals and health systems. The Company’s flagship product, DataArk®, is a solution that assists hospitals in retiring legacy clinical and patient accounting platforms and maintaining access to relevant data via a cloud-based software platform. Active archiving grants users the necessary functionality of a legacy system without the expense and risks. Data is kept active for quickly retrieving files, easily updating old records and continuing to bill accounts. MediQuant serves nearly 200 individual health systems which represent more than 1,000 hospital and physician practice customers. For more information, visit www.mediquant.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20190226006009/en/ River Communications

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Encore Health Resources Patents

Encore Health Resources has filed 20 patents.

The 3 most popular patent topics include:

  • Ophthalmology
  • Vision
  • Corrective lenses
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2016

8/7/2018

Ophthalmology, Vision, Diseases of the eye and adnexa, Piperazines, Piperidines

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/20/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/7/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Ophthalmology, Vision, Diseases of the eye and adnexa, Piperazines, Piperidines

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.